Avalo Therapeutics (AVTX) Price to Sales (2016 - 2026)
Avalo Therapeutics (AVTX) Price to Sales (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
P/S |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
44.65 Mn |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3,489.70 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
41.13 |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
9.26 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
17,434.90 |
| 10 |
Avalo Therapeutics |
296.38 Mn |
296.38 Mn |
- |
373.46 |
| Date | Value |
|---|
| Mar 30, 2026 |
373.46 |
| Mar 27, 2026 |
372.39 |
| Mar 26, 2026 |
373.99 |
| Mar 25, 2026 |
373.99 |
| Mar 24, 2026 |
360.59 |
| Mar 23, 2026 |
361.93 |
| Mar 20, 2026 |
359.79 |
| Mar 19, 2026 |
381.23 |
| Mar 18, 2026 |
393.57 |
| Mar 17, 2026 |
412.33 |
| Mar 16, 2026 |
429.49 |
| Mar 13, 2026 |
423.59 |
| Mar 12, 2026 |
447.99 |
| Mar 11, 2026 |
458.45 |
| Mar 10, 2026 |
453.75 |
| Mar 9, 2026 |
464.08 |
| Mar 6, 2026 |
464.08 |
| Mar 5, 2026 |
471.31 |
| Mar 4, 2026 |
492.23 |
| Mar 3, 2026 |
505.36 |
